143 related articles for article (PubMed ID: 34034473)
1. [Predicting response to non-small cell lung cancer immunotherapy using pre-treatment contrast-enhanced CT texture-based classification].
Shen LL; Tao GY; Fu HC; Liu XM; Ye XD; Ye JD
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):541-545. PubMed ID: 34034473
[No Abstract] [Full Text] [Related]
2. Pre-Immunotherapy Contrast-Enhanced CT Texture-Based Classification: A Useful Approach to Non-Small Cell Lung Cancer Immunotherapy Efficacy Prediction.
Shen L; Fu H; Tao G; Liu X; Yuan Z; Ye X
Front Oncol; 2021; 11():591106. PubMed ID: 33968716
[No Abstract] [Full Text] [Related]
3. [Development of a radiomics signature to predict Ki-67 expression level in non-small cell lung cancer].
Gu Q; Feng Z; Liang Q; Li M; Wang W; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1216-1222. PubMed ID: 30643066
[TBL] [Abstract][Full Text] [Related]
4. [The value of CT radiomics in the prediction of EGFR mutation in lung cancer].
Yu YX; Wang XM; Shi C; Hu S; Hu CH
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):690-695. PubMed ID: 32187913
[No Abstract] [Full Text] [Related]
5. Improved window adaptive gray level co-occurrence matrix for extraction and analysis of texture characteristics of pulmonary nodules.
Chen H; Li W; Zhu Y
Comput Methods Programs Biomed; 2021 Sep; 208():106263. PubMed ID: 34265545
[TBL] [Abstract][Full Text] [Related]
6. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
[TBL] [Abstract][Full Text] [Related]
7. Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.
Song F; Song X; Feng Y; Fan G; Sun Y; Zhang P; Li J; Liu F; Zhang G
Med Phys; 2023 Jul; 50(7):4351-4365. PubMed ID: 36682051
[TBL] [Abstract][Full Text] [Related]
8. Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
Ma ZP; Li XL; Gao K; Zhang TL; Wang HD; Zhao YX
J Xray Sci Technol; 2023; 31(6):1333-1340. PubMed ID: 37840466
[TBL] [Abstract][Full Text] [Related]
9. CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma.
Li Y; Xu X; Weng S; Yan C; Chen J; Ye R
J Digit Imaging; 2020 Dec; 33(6):1365-1375. PubMed ID: 32968880
[TBL] [Abstract][Full Text] [Related]
10. [Texture analysis of diffusion-weighted magnetic resonance imaging to identify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis].
Zhong X; Li JS; Chen ZJ; Yin JX; Gui S; Sun ZQ; Tang HS
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):37-42. PubMed ID: 32023697
[No Abstract] [Full Text] [Related]
11. Quantitative CT texture analysis in predicting PD-L1 expression in locally advanced or metastatic NSCLC patients.
Bracci S; Dolciami M; Trobiani C; Izzo A; Pernazza A; D'Amati G; Manganaro L; Ricci P
Radiol Med; 2021 Nov; 126(11):1425-1433. PubMed ID: 34373989
[TBL] [Abstract][Full Text] [Related]
12. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
13. Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.
Vaidya P; Bera K; Patil PD; Gupta A; Jain P; Alilou M; Khorrami M; Velcheti V; Madabhushi A
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33051342
[TBL] [Abstract][Full Text] [Related]
14. Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer.
Ge S; Yixing Y; Jia D; Ling Y
BMC Med Imaging; 2022 Sep; 22(1):166. PubMed ID: 36104679
[TBL] [Abstract][Full Text] [Related]
15. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.
Khorrami M; Prasanna P; Gupta A; Patil P; Velu PD; Thawani R; Corredor G; Alilou M; Bera K; Fu P; Feldman M; Velcheti V; Madabhushi A
Cancer Immunol Res; 2020 Jan; 8(1):108-119. PubMed ID: 31719058
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of computed tomography texture features between pulmonary inflammatory nodules and lung cancer].
E LN; Zhang N; Wang RH; Wu ZF
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):847-850. PubMed ID: 30481937
[No Abstract] [Full Text] [Related]
17. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the value of enhanced CT combined with texture analysis in the differential diagnosis of pulmonary sclerosing pneumocytoma and atypical peripheral lung cancer: a feasibility study.
Luo C; Song Y; Liu Y; Wang R; Gao J; Yue S; Ding C
BMC Med Imaging; 2022 Feb; 22(1):16. PubMed ID: 35105314
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy.
Ahn SY; Park CM; Park SJ; Kim HJ; Song C; Lee SM; McAdams HP; Goo JM
Invest Radiol; 2015 Oct; 50(10):719-25. PubMed ID: 26020832
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
